196 related articles for article (PubMed ID: 29068693)
1. In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles.
Price DN; Stromberg LR; Kunda NK; Muttil P
Mol Pharm; 2017 Dec; 14(12):4741-4750. PubMed ID: 29068693
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Delivery of Magnetically Targeted Nano-in-Microparticles.
McBride AA; Price DN; Muttil P
Methods Mol Biol; 2017; 1530():369-378. PubMed ID: 28150215
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Characterization of Magnetic Nano-in-Microparticles for Pulmonary Delivery.
McBride AA; Price DN; Muttil P
Methods Mol Biol; 2017; 1530():99-108. PubMed ID: 28150197
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery.
McBride AA; Price DN; Lamoureux LR; Elmaoued AA; Vargas JM; Adolphi NL; Muttil P
Mol Pharm; 2013 Oct; 10(10):3574-81. PubMed ID: 23964796
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
Tewes F; Ehrhardt C; Healy AM
Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
[TBL] [Abstract][Full Text] [Related]
6. A multilayer hollow nanocarrier for pulmonary co-drug delivery of methotrexate and doxorubicin in the form of dry powder inhalation formulation.
Nozohouri S; Salehi R; Ghanbarzadeh S; Adibkia K; Hamishehkar H
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():752-761. PubMed ID: 30889750
[TBL] [Abstract][Full Text] [Related]
7. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.
Stocke NA; Meenach SA; Arnold SM; Mansour HM; Hilt JZ
Int J Pharm; 2015 Feb; 479(2):320-8. PubMed ID: 25542988
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
[TBL] [Abstract][Full Text] [Related]
9. Development of Inhalable Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in Microparticulate System for Antituberculosis Drug Delivery.
Miranda MS; Rodrigues MT; Domingues RMA; Costa RR; Paz E; Rodríguez-Abreu C; Freitas P; Almeida BG; Carvalho MA; Gonçalves C; Ferreira CM; Torrado E; Reis RL; Pedrosa J; Gomes ME
Adv Healthc Mater; 2018 Aug; 7(15):e1800124. PubMed ID: 29797461
[TBL] [Abstract][Full Text] [Related]
10. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q
Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228
[TBL] [Abstract][Full Text] [Related]
11. Daunomycin-loaded superparamagnetic iron oxide nanoparticles: Preparation, magnetic targeting, cell cytotoxicity, and protein delivery research.
Liu MC; Jin SF; Zheng M; Wang Y; Zhao PL; Tang DT; Chen J; Lin JQ; Wang XH; Zhao P
J Biomater Appl; 2016 Aug; 31(2):261-72. PubMed ID: 27288463
[TBL] [Abstract][Full Text] [Related]
12. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
13. Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery.
Silva AS; Sousa AM; Cabral RP; Silva MC; Costa C; Miguel SP; Bonifácio VDB; Casimiro T; Correia IJ; Aguiar-Ricardo A
Int J Pharm; 2017 Mar; 519(1-2):240-249. PubMed ID: 28111281
[TBL] [Abstract][Full Text] [Related]
14. Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery.
Chen J; Shi M; Liu P; Ko A; Zhong W; Liao W; Xing MM
Biomaterials; 2014 Jan; 35(4):1240-8. PubMed ID: 24239110
[TBL] [Abstract][Full Text] [Related]
15. Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates.
Poh W; Ab Rahman N; Ostrovski Y; Sznitman J; Pethe K; Loo SCJ
Drug Deliv; 2019 Dec; 26(1):1039-1048. PubMed ID: 31691600
[TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
Kumar P; Agnihotri S; Roy I
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
[TBL] [Abstract][Full Text] [Related]
18. The combined magnetic field and iron oxide-PLGA composite particles: Effective protein antigen delivery and immune stimulation in dendritic cells.
Saengruengrit C; Ritprajak P; Wanichwecharungruang S; Sharma A; Salvan G; Zahn DRT; Insin N
J Colloid Interface Sci; 2018 Jun; 520():101-111. PubMed ID: 29529457
[TBL] [Abstract][Full Text] [Related]
19. Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy.
Scialabba C; Licciardi M; Mauro N; Rocco F; Ceruti M; Giammona G
Eur J Pharm Biopharm; 2014 Nov; 88(3):695-705. PubMed ID: 25281781
[TBL] [Abstract][Full Text] [Related]
20. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
Zhong Q
AAPS PharmSciTech; 2018 Feb; 19(2):531-540. PubMed ID: 28840529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
